Status:

UNKNOWN

A Prospective, Open-label, Single-arm Clinical Study

Lead Sponsor:

Sun Yat-sen University

Conditions:

Recurrent Glioblastoma Multiforme

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

the study is a prospective, single-arm, open-label trial, designed to explore the efficacy and safety of Tumor-Treating Fields (TTFields) combined with second-line chemotherapy treatment in recurrent ...

Detailed Description

PAST CLINICAL EXPERIENCE: The effect of the electric fields generated by the TTFields has been tested in two Ⅲ phase trials in humans(EF-11\&EF-14). The data from these trials suggest TTFields may im...

Eligibility Criteria

Inclusion

  • Sign written informed consent prior to any procedure related to the study;
  • Recurrence and pathologically confirmed WHO Grade IV glioblastoma (GBM);
  • The tumor is located in the supratentorial area
  • Age ≥18 years;
  • Received radiotherapy and maintenance treatment with temozolomide;
  • Expected survival time: \> 3 months;
  • KPS score ≥60;
  • Ability to comply with the plan;

Exclusion

  • Other clinical trials are being tried
  • Had major surgery within 4 weeks before the start of the study or had not recovered after the surgery
  • Received radiotherapy within 4 weeks before the study
  • Received chemotherapy within 4 weeks before the study
  • Women during pregnancy;
  • Allergic to hydrogels;
  • There are important implants in the body, such as pacemaker, defibrillator, shunt tube, deep brain stimulator, etc.;
  • Patients with significantly increased intracranial pressure (shifted \>5mm in imaging midline, obvious papilloma, nausea, vomiting, and decreased consciousness)

Key Trial Info

Start Date :

April 1 2020

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

July 1 2022

Estimated Enrollment :

40 Patients enrolled

Trial Details

Trial ID

NCT04689087

Start Date

April 1 2020

End Date

July 1 2022

Last Update

December 30 2020

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Sun Yat-sen University Cancer Center

Guangzhou, Guangdong, China, 510000